Solve Therapeutics Announces Mission to Advance Novel Antibody-Based Therapies Against Cancer-Specific Targets

/PRNewswire/ -- Solve Therapeutics, Inc. (SolveTx), an oncology-focused biopharmaceutical company, announced today its mission to develop novel antibody-based...

Related Keywords

San Diego ,California ,United States ,University Of California San Diego ,Jeff Watkins ,Dave Johnson ,Yakovn Kogan ,Langdon Miller ,Acerta Pharma ,Brian Lannutti ,Astrazeneca ,Prnewswire Solve Therapeutics Inc ,Velosbio Inc ,Therapeutics Inc ,Protein Technology ,Translational Sciences ,Chief Executive Officer ,Executive Vice President ,Chief Medical Officer ,Senior Vice President ,Katti Jessen ,Matrix Capital Management ,Decheng Capital ,General Atlantic ,California San Diego ,Vice President ,